SRDX SurModics
- 41.940
- +0.030+0.07%
- 41.940
- 0.0000.00%
SurModics News
Surmodics (SRDX) Inks Group Purchasing Agreement With Premier
Surmodics Signs Group Purchasing Deal With Premier
Surmodics (SRDX) said Monday it has signed a group purchasing agreement with Premier, covering Surmodics' thrombectomy products. Financial details weren't disclosed. The deal gives Premier members spe
Express News | Surmodics Awarded Thrombectomy Products Agreement With Premier, Inc.
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Surmodics, Inc. Buyout
Wilmington, Delaware--(Newsfile Corp. - June 4, 2024) - Rigrodsky Law, P.A. is investigating Surmodics, Inc. ("Surmodics") (NASDAQ: SRDX) regarding possible breaches of fiduciary duties and other viol
Surmodics (SRDX) Enters Deal to Be Acquired by GTCR for $627M
Assessing Surmodics: Insights From 5 Financial Analysts
Surmodics (NASDAQ:SRDX) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.The table below offers a condensed view of their rec
SurModics (SRDX) Was Downgraded to a Hold Rating at Barrington
Express News | Surmodics Inc : Barrington Research Cuts to Market Perform From Outperform
Surmodics, Inc.'s (NASDAQ:SRDX) 63% Share Price Surge Not Quite Adding Up
Surmodics, Inc. (NASDAQ:SRDX) shares have had a really impressive month, gaining 63% after a shaky period beforehand. The last month tops off a massive increase of 130% in the last year. After su
ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition of Surmodics, Inc.
Rowley Law PLLC is investigating potential securities law violations by Surmodics, Inc. (NASDAQ: SRDX) and its board of directors concerning the...
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Bank of Montreal (NYSE:BMO) fell sharply during Wednesday's session after the company reported worse-than-expected second-quarter financial results.Bank of Montreal posted quarterly adjusted
Surmodics Cut to Neutral From Buy by Sidoti & Co.
Surmodics Cut to Neutral From Buy by Sidoti & Co.
Surmodics Price Target Announced at $43.00/Share by Sidoti & Co.
Surmodics Price Target Announced at $43.00/Share by Sidoti & Co.
Express News | Sidoti & Co. Downgrades Surmodics to Neutral, Announces $43 Price Target
Why Is Medical Coating Specialist Surmodics Trading Higher On Wednesday?
Private equity firm GTCR agreed to acquire medical device coating company Surmodics Inc (NASDAQ:SRDX) for approximately $627 million, or $43 per share.The per-share acquisition price represents a 41.1
Shareholder Alert: Ademi LLP Investigates Whether Surmodics, Inc. Has Obtained a Fair Price for Its Public Shareholders
MILWAUKEE, May 29, 2024 /PRNewswire/ -- Ademi LLP is investigating Surmodics (Nasdaq: SRDX) for possible breaches of fiduciary duty and other violations of law in its transaction with GTCR. Click her
Heico Posts Upbeat Earnings, Joins Surmodics, Abercrombie & Fitch And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were lower, with the Dow Jones index falling more than 300 points on Wednesday.Shares of HEICO Corporation (NYSE:HEI) rose sharply during Wednesday's session following a second-quarter ear
Express News | Needham Downgrades Surmodics to Hold
Surmodics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/29/2024 — Needham Downgrades Buy → Hold 05/02/2024 68.29% Barrington Research $71 → $71 Maintains Outp
SurModics (SRDX) Was Downgraded to a Hold Rating at Needham
Analysis
Price Target
No Data
